Decompression Illness Treated with the Hart-Kindwall Protocol in a Monoplace Chamber.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
12 Jun 2022
Historique:
entrez: 12 6 2022
pubmed: 13 6 2022
medline: 15 6 2022
Statut: epublish

Résumé

BACKGROUND Hyperbaric oxygen (HBO₂) therapy in a multiplace chamber is the standard treatment for severe altitude decompression illness (DCI). However, some hospitals may only have a monoplace chamber. Herein, we present the case of a patient with severe altitude DCI caused by rapid decompression during an actual flight operation that was successfully treated through emergency HBO₂ therapy with the Hart-Kindwall protocol, a no-air-break tables with the minimal-pressure oxygen approach in a monoplace chamber due to unavailability of rapid access to a multiplace chamber. CASE REPORT A 34-year-old male aviator presented with chest pain, paresthesia, and mild cognitive impairment following rapid decompression 20 minutes after take-off, which comprised 10 minutes of reaching a height of 10 058 m (33 000 feet) and 10 minutes of cruising at that altitude. He then initiated flight descent and landing. He visited a primary clinic, and severe DCI was suggested clinically. However, since the closest hospital with a multiplace chamber was a 3-hour drive away, we provided emergency HBO₂ therapy with the Hart-Kindwall protocol in a monoplace chamber at a nearby hospital 4 hours after the initial decompression. He recovered fully and returned to flight duty 2 weeks later. CONCLUSIONS Emergency HBO₂ therapy with the Hart-Kindwall protocol in a monoplace chamber may be a suitable option for severe DCI, especially in remote locations with no access to facilities with a multiplace chamber. However, prior logistical coordination must be established to transfer patients to hospitals with multiplace chambers if their symptoms do not resolve.

Identifiants

pubmed: 35690900
pii: 935534
doi: 10.12659/AJCR.935534
pmc: PMC9201989
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e935534

Références

Undersea Hyperb Med. 2003 Summer;30(2):147-53
pubmed: 12964858
PLoS One. 2012;7(11):e50079
pubmed: 23185538
Aviat Space Environ Med. 1996 Mar;67(3):199-206
pubmed: 8775396
Lancet. 2011 Jan 8;377(9760):153-64
pubmed: 21215883
Aviat Space Environ Med. 1989 Mar;60(3):256-62
pubmed: 2653301
Aviat Space Environ Med. 1996 Oct;67(10):983-9
pubmed: 9025822
Aviat Space Environ Med. 1990 Aug;61(8):685-9
pubmed: 2400370
Aviat Space Environ Med. 1990 Sep;61(9):833-6
pubmed: 2241750
Aviat Space Environ Med. 1991 Oct;62(10):994-6
pubmed: 1764015
Aerosp Med. 1974 Oct;45(10):1190-3
pubmed: 4429061
Aviat Space Environ Med. 2006 Oct;77(10):1003-8
pubmed: 17042243
Cochrane Database Syst Rev. 2012 May 16;(5):CD005277
pubmed: 22592704

Auteurs

Yoshiaki Inuzuka (Y)

Surgen General, Air Staff Office, Japan Air Self Defense Force, Ministry of Defense, Tokyo, Japan.

Naoki Edo (N)

Surgen General, Air Staff Office, Japan Air Self Defense Force, Ministry of Defense, Tokyo, Japan.
Department of Clinical Research Medicine, Teikyo University School of Medicine, Tokyo, Japan.

Yuichi Araki (Y)

Department of Emergency and Intensive Care, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.

Takafumi Hoshi (T)

Medical Squadron, Air Base Group, 7th Air Wing, Central Air Defense Force, Air Defense Command, Japan Air Self Defense Force, Ministry of Defense, Omitama, Ibaraki, Japan.

Mayuko Maruta (M)

Surgen General, Air Staff Office, Japan Air Self Defense Force, Ministry of Defense, Tokyo, Japan.

Nana Nakamoto (N)

Medical Squadron, Air Base Group, 7th Air Wing, Central Air Defense Force, Air Defense Command, Japan Air Self Defense Force, Ministry of Defense, Omitama, Ibaraki, Japan.

Shinya Suzuki (S)

Hyperbaric Oxygen Therapy Division, Department of Emergency Medicine, Kameda General Hospital, Kamogawa, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH